USPTO serial 79454330
Reviewed by CopyMark Law Group
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceuticals; medicines containing iron; oral iron compositions for the treatment of iron deficiency and/or anaemia; medicines containing endopeptidases; oral peptidases compositions for the treatment of gluten intolerance; orally administered enzymatic compositions for the treatment and management of gluten intolerance in patients with celiac disease; pharmaceuticals and medicines for the treatment of nutritional disorders and nutritional deficiencies; dietiary supplements; dietary supplements containing iron; dietary supplements containing folic acid; vitamins. | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 29, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 28, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 23, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 17, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 17, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 16, 2026 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |